Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole
NCT04903353Phase 4Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Feb 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole, risperidone in Autism Spectrum Disorder (ASD), sponsored by Vanderbilt University Medical Center. Started Feb 2022; status: completed.
02
Drugs
aripiprazolerisperidone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT04903353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04903353.